Filter posts

The BioGENEius Challenge: Prarthana Dalal

By Prarthana Dalal, 2011 International BioGENEius Challenge 1st Place Winner Project Title: Modeling of human …

The BioGENEius Challenge: Priyen Patel

By Priyen Patel, 2011 U.S. National BioGENEius Media Award Winner Project Title: Over-the-Counter and In …

BIO CEO Company Snapshot: ImmunoGen, Inc.

In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New …

Is the Polio Vaccine an Anti-Patent Success Story?

By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader: …

Managing in a Cost-Constrained Environment

By Jill E. Sackman, D.V.M., Ph.D., Senior Consultant, and Matt Levy, J.D., Business Analyst, at …

Let's Get PDUFA V Approved, Fast

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At …

Biopharma Industry Enthusiastic About 2012

By Eric S. Langer, president and managing partner, BioPlan Associates, Inc. 2012 Annual Study shows budgets, …

"America Speaks" Poll Shows Health Research is Key to Economic Recovery

By Mary Woolley, President of Research!America Research!America’s 12th edition of America Speaks, an annual summary …

HIV/AIDS and Biotechnology

By David Welch, President/Senior Producer at M2 MultiMedia When the HIV/AIDS epidemic became widely known in …

IBM's Watson: From Jeopardy! to Drug Research

Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available …